These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 4405395

  • 1. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S, Nozima T.
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract] [Full Text] [Related]

  • 2. Delayed hypersensitivity in vaccinia-infected mice. I. Antigen(s) responsible for developing delayed hypersensitivity.
    Ueda S, Nozima T.
    Acta Virol; 1969 Nov; 13(6):532-7. PubMed ID: 4391721
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of vaccinia virus replication in skin of tuberculin-sensitized animals challenged with PPD.
    Lodmell DL, Ewalt LC, Notkins AL.
    J Immunol; 1976 Nov; 117(5 Pt.2):1757-61. PubMed ID: 62789
    [Abstract] [Full Text] [Related]

  • 4. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    Schultz RM, Woan MC, Tompkins WA.
    J Reticuloendothel Soc; 1974 Jul; 16(1):37-47. PubMed ID: 4137839
    [No Abstract] [Full Text] [Related]

  • 5. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens].
    Andrzejewski J, Bogunowicz A, Zajac I.
    Zentralbl Bakteriol Orig; 1968 Jul; 207(3):419-21. PubMed ID: 5745681
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of basophilic leukocytes in cellular immunity to vaccinia virus infection.
    Dvorak HF, Hirsch MS.
    J Immunol; 1971 Dec; 107(6):1576-82. PubMed ID: 5120398
    [No Abstract] [Full Text] [Related]

  • 8. Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms.
    Prasad CB, Hedström KG.
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):97-111. PubMed ID: 4377639
    [No Abstract] [Full Text] [Related]

  • 9. Immune response in rabbits to ultraviolet vaccinia virus.
    Wrzos H, Zakrzewski K.
    Arch Immunol Ther Exp (Warsz); 1974 Nov; 22(6):735-44. PubMed ID: 4451441
    [No Abstract] [Full Text] [Related]

  • 10. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y, Manischewitz J, Meseda CA, Merchlinsky M, Vassell RA, Sirota L, Berkower I, Golding H, Weiss CD.
    J Infect Dis; 2007 Oct 01; 196(7):1026-32. PubMed ID: 17763325
    [Abstract] [Full Text] [Related]

  • 11. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y.
    Virology; 1996 Mar 15; 217(2):478-85. PubMed ID: 8610439
    [Abstract] [Full Text] [Related]

  • 12. Infection of rabbit alveolar macrophages with a neurotropic vaccinia virus strain in vitro.
    Benda R, Danes L, Cinátl J.
    Acta Virol; 1970 Sep 15; 14(5):353-61. PubMed ID: 4394660
    [No Abstract] [Full Text] [Related]

  • 13. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y, Tagaya I.
    J Exp Med; 1973 Nov 01; 138(5):1033-43. PubMed ID: 4744920
    [Abstract] [Full Text] [Related]

  • 14. The role of alveolar macrophages in inhalation infection of rabbits with vaccinia virus. I. Experiments with large doses of virus.
    Danes L, Benda R, Kruml J, Jelínková A.
    Acta Virol; 1969 Nov 01; 13(6):521-6. PubMed ID: 4391719
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization.
    Chapes SK, Tompkins WA.
    J Immunol; 1979 Jul 01; 123(1):303-10. PubMed ID: 87476
    [No Abstract] [Full Text] [Related]

  • 16. Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.
    Ueda S, Wakamiya N, Wu KS, Kato S, Fujiwara H, Hamaoka T.
    Biken J; 1984 Mar 01; 27(1):1-7. PubMed ID: 6385960
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC, Goenaga J, Wittek R, Rindisbacher L.
    Virology; 1999 Feb 01; 254(1):71-80. PubMed ID: 9927575
    [Abstract] [Full Text] [Related]

  • 18. [Immunity after producing vaccinia generalisata during treatment with L-asparaginase in rabbits (author's transl)].
    Ricken KH, Ehrengut W.
    Immun Infekt; 1974 Feb 01; 2(1):78-82. PubMed ID: 4468263
    [No Abstract] [Full Text] [Related]

  • 19. Influenza virus infection in mice: the effect of avirulent virus infection on the pathogenicity of highly virulent virus.
    Kurimura T, Hirano A, Suzuki N, Okuno Y.
    Biken J; 1971 Mar 01; 14(1):65-73. PubMed ID: 5090680
    [No Abstract] [Full Text] [Related]

  • 20. Soluble antigens of vaccinia virus. Note I. Chemical and biological properties. Immunogenic capacity.
    Mihăilescu R, Olinescu A, Popa L, Stavri H, Iancu L.
    Arch Roum Pathol Exp Microbiol; 1987 Mar 01; 46(1):35-46. PubMed ID: 2449147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.